Navigation Links
Cynosure's Cellulaze Cellulite Laser Work Station Receives Korean Regulatory Approval
Date:11/30/2011

WESTFORD, Mass., Nov. 30, 2011 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based treatments for minimally invasive and non-invasive aesthetic applications, today announced that it has received market approval from the Korea Food & Drug Administration (KFDA) for its Cellulaze™ Cellulite Laser Workstation.  Sales through Cynosure Korea, the Company's wholly owned subsidiary in Seoul, Korea, are expected to begin in the first quarter of 2012.

Cellulaze is the world's first minimally invasive aesthetic device designed for the long-term reduction of cellulite. The product received CE Mark certification in February 2011, and is currently being marketed in the European Union.  Cellulaze also is cleared for marketing in Australia and Canada. Cynosure's 510(k) application for marketing clearance of Cellulaze in the United States is being reviewed by the U.S. Food and Drug Administration.

"Success in international markets remains key to our long-term growth strategy," said Michael Davin, Cynosure's president and chief executive officer.  "The KFDA's approval of Cellulaze reflects both the increasing global adoption of this highly effective solution for long-term cellulite reduction, and our ongoing progress in bringing Cynosure's innovative technology to consumers worldwide."

Approximately 85% of women over the age of 20(1,2) have some form of cellulite – pockets of fat deposited just beneath the surface of the skin, around the hips, thighs, and buttocks, which produces an "orange-peel" or a "cottage cheese" appearance(3). In the United States alone, treatment of cellulite is a multibillion-dollar industry, according to market estimates.

Cellulaze uses a proprietary SideLight 3D™ side-firing technology to target the exact causes of cellulite beneath the skin: herniated pockets of fat, stiffened septae and thin skin. During the procedure, a tiny laser fiber is inserted under the skin, which gently heats the skin and disrupts or melts the fat. Next the laser releases the fibrous bands that create the dimpling effect from pulling down on the skin. This release creates a smoother look.  Finally the laser's energy stimulates collagen production to increase skin's depth and elasticity for a more even, healthier appearance.Patients usually see improvements within a few weeks, with the most significant results continuing to develop for a few months following the procedure.  Cellulaze also complements other body shaping technologies, such as Cynosure's Smartlipo™ family of workstations. Together, these technologies synergistically deliver the benefits of cellulite reduction and skin tightening through tissue coagulation.  

About Cynosure, Inc.
Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions, rejuvenate the skin, liquefy and remove unwanted fat through laser lipolysis, reduce the appearance of cellulite and treat Onychomycosis. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulse dye, Q-switched, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991. For corporate or product information, contact Cynosure at 800-886-2966, or visit www.cynosure.com.

Forward-Looking Statements
Any statements in this press release about future expectations, plans and prospects for Cynosure, Inc., as well as other statements containing the words "believes," "anticipates," "plans," "expects," "will" and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including the global economy and lending environment and their effects on the aesthetic laser industry, Cynosure's history of operating losses, its reliance on sole source suppliers, the inability to accurately predict the timing or outcome of regulatory decisions, changes in consumer preferences, competition in the aesthetic laser industry, economic, market, technological and other factors discussed in Cynosure's most recent Annual Report on Form 10-K, which is filed with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent Cynosure's views as of the date of this press release. Cynosure anticipates that subsequent events and developments will cause its views to change. However, while Cynosure may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Cynosure's views as of any date subsequent to the date of this press release.

 

(1) Harvard Women's Health Watch Cellulite meltdown. Harv. Health Pub. Group 5, 7 (1998).
(2) Sainio, E.L., Rantanen, T. and Kanerva, L. Ingredients and safety of cellulite creams. Eur. J. Dermatol. 10, 596–603 (2000).
(3) Drealos, Z.D. and Marenus, K.D. Cellulite: etiology and purported treatment. Dermatol. Surg. 23, 1177–1181 (1997).  Timothy Baker Scott SolomonExecutive VP, Treasurer and CFO

 

Vice President Cynosure, Inc.

 

Sharon Merrill 978.256.4200

 

617.542.5300TBaker@cynosure.com

 

CYNO@investorrelations.com 


'/>"/>
SOURCE Cynosure, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cynosure Introduces Cellulaze, the Worlds First Aesthetic Laser Device for the Long-Term Reduction of Cellulite
2. Cynosure Receives Additional International Regulatory Approvals for New Cellulite Reduction Workstations
3. Cynosure Receives International Marketing Clearances for New Cellulite, Laser Lipolysis Products
4. American Laser Center Offers VelaShape Body Shaping and Cellulite Reduction Treatment
5. Ellman International Introduces the New Ellumine Laser at the American Society for Dermatologic Surgery (ASDS) 2011 Annual Meeting
6. IRIDEX Launches New MicroPulse™ Module Targeting the Broad Ophthalmology Laser Photocoagulation Market
7. Aesthetic Lasers and Energy Devices - Global Market Briefing to 2017
8. XTRAC Excimer Laser Provides Relief for Psoriasis Sufferers Fall Flare-Ups
9. In Honor of National Breast Cancer Awareness Month, Alma Lasers Launches Nationwide Radiation Tattoo Removal Program, Declare Your Freedom
10. Cynosure Acquires Worldwide Exclusive Rights to Distribute PinPointe™ FootLaser™ for Treatment of Onychomycosis
11. In Support of National Breast Cancer Awareness Month, Alma Lasers Launches Nationwide Radiation Tattoo Removal Program, Declare Your Freedom.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... CAMBRIDGE, Mass. , June 24, 2016 /PRNewswire/ ... the Spaulding Rehabilitation Network,s Dean Center for ... of Physical Medicine and Rehabilitation, MIT Hacking Medicine, ... Center for Innovation, today announced the five finalists ... Hackathon for Lyme disease.  More than 100 scientists, ...
(Date:6/24/2016)... ALEXANDRIA, Va. , June 24, 2016 ... a set of recommendations that would allow ... information (HCEI) with entities that make formulary and coverage ... determine the "value" of new medicines. The ... that does not appear on the drug label, a ...
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... "The World Market for Companion Diagnostic Tests" report to ... World Market for Companion Diagnostics The World ... diagnostic and personalized medicine diagnostics. Market analysis in the report ... Diagnostics Test Market (In Vitro Diagnostic Kits) by Region (N. ...
Breaking Medicine Technology:
(Date:6/24/2016)... Rhinebeck, NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of ... of companies that call for a minimum wage raise to $12 an hour by 2020 ... wage. This will restore the lost value of the minimum wage, assure the wage floor ...
(Date:6/24/2016)... ... 24, 2016 , ... EB Medicine presented its first-ever “Issue ... conference in Ponte Vedra Beach, FL. The awards honor the outstanding work of ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
(Date:6/24/2016)... ... ... recruitment firm Slone Partners is pleased to announce the placement of Suzanne ... of North American Capital Sales at HTG Molecular . , In ... commercialization of the HTG EdgeSeq system and associated reagents in North America. , Headquartered ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, MTI-GlobalStem, a provider ... and other difficult to transfect cells, announces its launch of the PluriQ™ G9™ ... Editing System is a complete system for culturing and transfecting human pluripotent ...
Breaking Medicine News(10 mins):